Income Taxes

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

For the three months ended March 31, 2023, we recorded an income tax expense of $1.9 million compared with an income tax benefit of $2.5 million for the three months ended March 31, 2022. Our effective tax rate was -10.1% for the three months ended March 31, 2023, compared with -34.8% in the prior year period. The tax rate for 2023 reflects a tax expense on a pre-tax loss consistent with the prior year period. The change in our income tax expense and our effective tax rate were primarily due to the continued impact of the capitalization of research and development (“R&D”) expenditures for income tax purposes. The Tax Cuts and Jobs Act (the “Act”) requires the capitalization and amortization of R&D costs incurred after December 31, 2021. We have considered the continued effects of the Act on the forecasted domestic taxable income for the year ending December 31, 2023. Our entity in the United States remains in a full valuation allowance position, hence we were not able to recognize the tax benefits associated with the capitalization of these R&D expenditures.

Our quarterly estimate of our annual effective tax rate, and our quarterly provision for income tax (benefit) expense, are subject to significant variation due to numerous factors, including variability in accurately predicting our pretax and taxable income or loss and the mix of jurisdictions to which they relate, as well as the amount of pretax income or loss recognized during the quarter.